Markets.com Logo

TBIO

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    0.0217$
  • Previous Close
    0.0217$
  • 52 Week Change
    5.07$
  • Day Range
    0.00$
  • 52 Week High/Low
    0.012$ - 5.08$
  • Dividend Per Share
    --
  • Market cap
    39 068$
  • EPS
    -4.0938
  • Beta
    2.783
  • Volume
    --

About

TBIO.US represents the common stock of Translate Bio, Inc., a company formerly focused on developing messenger RNA (mRNA) therapeutics. Translate Bio was acquired by Sanofi in August 2021. Therefore, TBIO.US is no longer actively traded on the stock market, and its price history reflects its value prior to the acquisition. Prior to its acquisition, Translate Bio focused on developing mRNA therapeutics for various diseases, including cystic fibrosis and liver diseases.
DAX 30 technical outlook: What are the future predictions for the DAX?

DAX 30 technical outlook: What are the future predictions for the DAX?

Ghko B|--
Crypto Market Outlook 2026: BTC Eyes $100K–$200K, ETH Bullish Scenario, XRP Prediction

Crypto Market Outlook 2026: BTC Eyes $100K–$200K, ETH Bullish Scenario, XRP Prediction

Ghko B|--
XRP Price Prediction: Will XRP (Ripple) Outperform Bitcoin (BTC/USD) in 2026?

XRP Price Prediction: Will XRP (Ripple) Outperform Bitcoin (BTC/USD) in 2026?

Ghko B|--
Stock market analysis: Dow Jones (DJIA), S&P 500 and Nasdaq close higher today

Stock market analysis: Dow Jones (DJIA), S&P 500 and Nasdaq close higher today

Frances Wang|--
Oil prices spike over $110: Will oil prices keep going up amid Middle East crisis?

Oil prices spike over $110: Will oil prices keep going up amid Middle East crisis?

Ghko B|--
Stellar (XLM) price analysis: Will XLM/USD reach $1 in 2026?

Stellar (XLM) price analysis: Will XLM/USD reach $1 in 2026?

Ghko B|--
Crude oil prices continue to rise: How long could Middle East tensions keep international oil prices high?

Crude oil prices continue to rise: How long could Middle East tensions keep international oil prices high?

Ghko B|--

Factors

Clinical Trial Results: Positive data boosts investor confidence, driving up demand and stock price. Negative results or trial failures often lead to significant price drops.

Regulatory Approvals: FDA approval of TBIO's drugs or therapies is a major catalyst, increasing revenue potential and stock valuation. Rejections or delays can negatively impact the stock.

Market Sentiment: General market trends, investor optimism or pessimism, and the overall health of the biotechnology sector influence TBIO's stock price.

Competition: The presence of competing products or companies in the same therapeutic area can affect TBIO's market share and stock performance.

Financial Performance: Revenue, earnings, and profitability reports impact investor perception of TBIO's value and future growth prospects.

Partnerships and Acquisitions: Collaborations with other companies or potential acquisition targets can lead to increased stock value.

People Also Watch

Latest news

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

ESMA Expansion Sparks Crypto, Fintech Slowdown Concerns in EU

Noah Lee|--
Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Bitcoin's 'Santa' Rally: Fed Rate Decision and 2026 Outlook

Noah Lee|--
Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Western Union Unveils Stable Card, Stablecoin Strategy to Combat Inflation

Liam James|--

Latest Education Articles

Learn to trade: buy/sell stock CFDs online, how to invest in stocks in UAE?

Learn to trade: buy/sell stock CFDs online, how to invest in stocks in UAE?

Ghko B|--
CFD Trading & Markets: How do I register for CFD trading in the United Arab Emirates (UAE)?

CFD Trading & Markets: How do I register for CFD trading in the United Arab Emirates (UAE)?

Ghko B|--
CFD Trading & Markets: How to start CFD trading in United Arab Emirates?

CFD Trading & Markets: How to start CFD trading in United Arab Emirates?

Ghko B|--